Potential for therapy with AML-derived dendritic cells

被引：10

作者：

Claxton, D

Choudhury, A

机构：

[1] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Hershey, PA 17033 USA

[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

LEUKEMIA | 2001年 / 15卷 / 04期

关键词：

D O I：

10.1038/sj.leu.2402056

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：668 / 669

页数：2

共 5 条

[1] The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses [J].

Brouwer, RE ;

van der Hoorn, M ;

Kluin-Nelemans, HC ;

van Zelderen-Bhola, S ;

Willemze, R ;

Falkenburg, JHF .

HUMAN IMMUNOLOGY, 2000, 61 (06) :565-574

[2]

Charbonnier A, 1999, EUR J IMMUNOL, V29, P2567, DOI 10.1002/(SICI)1521-4141(199908)29:08<2567::AID-IMMU2567>3.0.CO

[3]

2-S

[4] Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses [J].

Choudhury, A ;

Liang, JC ;

Thomas, EK ;

Flores-Romo, L ;

Xie, QS ;

Agusala, K ;

Sutaria, S ;

Sinha, I ;

Champlin, RE ;

Claxton, DF .

BLOOD, 1999, 93 (03) :780-786

[5] Human leukemia-derived dendritic cells: Ex-vivo development of specific antileukemic cytotoxicity [J].

Choudhury, A ;

Toubert, A ;

Sutaria, S ;

Charron, D ;

Champlin, RE ;

Claxton, DF .

CRITICAL REVIEWS IN IMMUNOLOGY, 1998, 18 (1-2) :121-131

← 1 →